558 related articles for article (PubMed ID: 15720813)
1. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
[TBL] [Abstract][Full Text] [Related]
2. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
3. NHERF-1: modulator of glioblastoma cell migration and invasion.
Kislin KL; McDonough WS; Eschbacher JM; Armstrong BA; Berens ME
Neoplasia; 2009 Apr; 11(4):377-87. PubMed ID: 19308292
[TBL] [Abstract][Full Text] [Related]
4. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
5. N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation.
Deng Y; Yao L; Chau L; Ng SS; Peng Y; Liu X; Au WS; Wang J; Li F; Ji S; Han H; Nie X; Li Q; Kung HF; Leung SY; Lin MC
Int J Cancer; 2003 Sep; 106(3):342-7. PubMed ID: 12845671
[TBL] [Abstract][Full Text] [Related]
6. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.
Colin C; Baeza N; Bartoli C; Fina F; Eudes N; Nanni I; Martin PM; Ouafik L; Figarella-Branger D
Oncogene; 2006 May; 25(19):2818-26. PubMed ID: 16314830
[TBL] [Abstract][Full Text] [Related]
7. Effect of Concomitant Radiochemotherapy on Invasion Potential of Glioblastoma.
Hutóczki G; Bognár L; Tóth J; Scholtz B; Zahuczky G; Hanzély Z; Csősz É; Reményi-Puskár J; Kalló G; Hortobágyi T; Klekner A
Pathol Oncol Res; 2016 Jan; 22(1):155-60. PubMed ID: 26450124
[TBL] [Abstract][Full Text] [Related]
8. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
[TBL] [Abstract][Full Text] [Related]
10. The phosphorylation of ephrin-B2 ligand promotes glioma cell migration and invasion.
Nakada M; Anderson EM; Demuth T; Nakada S; Reavie LB; Drake KL; Hoelzinger DB; Berens ME
Int J Cancer; 2010 Mar; 126(5):1155-65. PubMed ID: 19728339
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
12. Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.
Yokota T; Kouno J; Adachi K; Takahashi H; Teramoto A; Matsumoto K; Sugisaki Y; Onda M; Tsunoda T
Acta Neuropathol; 2006 Jan; 111(1):29-38. PubMed ID: 16320026
[TBL] [Abstract][Full Text] [Related]
13. Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro.
Mariani L; Beaudry C; McDonough WS; Hoelzinger DB; Kaczmarek E; Ponce F; Coons SW; Giese A; Seiler RW; Berens ME
Clin Cancer Res; 2001 Aug; 7(8):2480-9. PubMed ID: 11489830
[TBL] [Abstract][Full Text] [Related]
14. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness.
Chigurupati S; Venkataraman R; Barrera D; Naganathan A; Madan M; Paul L; Pattisapu JV; Kyriazis GA; Sugaya K; Bushnev S; Lathia JD; Rich JN; Chan SL
Cancer Res; 2010 Jan; 70(1):418-27. PubMed ID: 20028870
[TBL] [Abstract][Full Text] [Related]
15. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Verma BK; Chickabasaviah YT; Arivazhagan A; Kondaiah P; Santosh V
J Neurooncol; 2021 Mar; 152(1):55-65. PubMed ID: 33389566
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
[TBL] [Abstract][Full Text] [Related]
17. The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.
Smith SJ; Diksin M; Chhaya S; Sairam S; Estevez-Cebrero MA; Rahman R
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156557
[TBL] [Abstract][Full Text] [Related]
18. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A
Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856
[TBL] [Abstract][Full Text] [Related]
19. Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines.
Jung TY; Jung S; Ryu HH; Jeong YI; Jin YH; Jin SG; Kim IY; Kang SS; Kim HS
J Neurosurg; 2008 Aug; 109(2):273-84. PubMed ID: 18671640
[TBL] [Abstract][Full Text] [Related]
20. NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature.
Al-Mayhani MT; Grenfell R; Narita M; Piccirillo S; Kenney-Herbert E; Fawcett JW; Collins VP; Ichimura K; Watts C
Neuro Oncol; 2011 Aug; 13(8):830-45. PubMed ID: 21798846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]